{"groups":[{"description":"Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) twice weekly for 12 weeks via a Codetron unit","id":"FG000","title":"ALTENS: Phase II"},{"description":"5mg pilocarpine by mouth 3 times a day for 12 weeks","id":"FG001","title":"Pilocarpine: Phase III"},{"description":"Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) twice weekly for 12 weeks via a Codetron unit","id":"FG002","title":"ALTENS: Phase III"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"}],"type":"Protocol Violation"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"4"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"9"}],"type":"Missing data"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"Incomplete treatment"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"}],"type":"Treatment completed outside of timeframe"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"5"}],"type":"Missing baseline form"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"73"},{"groupId":"FG002","numSubjects":"75"}],"type":"STARTED"},{"achievements":[{"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","groupId":"FG000","numSubjects":"44"},{"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","groupId":"FG001","numSubjects":"43"},{"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","groupId":"FG002","numSubjects":"53"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"30"},{"groupId":"FG002","numSubjects":"22"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}